Max Robotics — Global Service Robot Directory + US Certification

About

Matthew Hudnall is a urologic surgeon and researcher whose work focuses on health equity, surgical outcomes, and the optimization of robotic-assisted procedures in urologic oncology. His research primarily investigates disparities in access to robotic technology and the comparative effectiveness of robotic versus open surgery for prostate and bladder cancer. In his highly cited 2023 study, Hudnall identified significant disparities in access to robot-assisted radical prostatectomy (RARP) and their impact on perioperative outcomes, drawing on national cancer data to highlight systemic inequities. His earlier work at a Veterans Affairs hospital provided a contemporary comparison of open to robotic prostatectomy, demonstrating the unique challenges and outcomes in this population. Most recently, Hudnall has advanced surgical technique by evaluating the use of indocyanine green (ICG) during robotic radical cystectomy, showing that ICG significantly reduces ureteroenteric anastomotic stricture rates—the largest study of its kind with the longest follow-up. With over 27 citations across his key papers, Hudnall’s contributions are shaping both clinical practice and policy, making him a leading voice in equitable, evidence-based urologic surgery.